42Stockpicking

AMPH

Amphastar Pharmaceuticals IncKøb· 69.8%· 20. aug. 2026
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
6,3
4th %ile · 62p
EV/EBITDAi
1,4
9th %ile · 16p
P/Bi
2,2
23rd %ile · 64p
P/Si
0,8
18th %ile · 70p
EV/Salesi
0,7
15th %ile · 70p
Div yieldi

Kursudvikling

Kun 135 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 22.8.2026none
Prishistorik
0,5 år
Pris-dage
135
Årsregnskaber
15
Peers
0/0
Valuation
5/6
Fundamentals
8/8
Datovindue
2026-02-09 til 2026-08-21

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,5 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

AMPH vurderet 2026-08-22

Score
48.6%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

34%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

68%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

14%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

64%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

47%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

72%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

79%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 6.3 vs peer median 20.6; cheaper than peers if business quality is comparable.

Insider activity

Net 90d (aktier)
-16.153
Net 90d (værdi)
-345.738 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
11.8.2026PRINS RICHARD K▼ SALG-7.973-161.852 USDsec
7.8.2026PETERS WILLIAM JCFO, EVP & TREASURER◆ OPT.5.05399.999 USDsec
7.8.2026PETERS WILLIAM JCFO, EVP & TREASURER▼ SALG-8.180-183.886 USDsec
9.7.2026Pierce Anthony T· ANDET7.886sec
2.6.2026Lee Howard· ANDET-769-14.188 USDsec
1.6.2026Gaugh David Russell· ANDET8.143sec
1.6.2026Deflin Gayle· ANDET8.143sec
1.6.2026PRINS RICHARD K· ANDET8.143sec
1.6.2026Lee Howard· ANDET8.143sec
1.6.2026Gerst Diane G.· ANDET8.143sec
1.6.2026ZASLOFF MICHAEL A· ANDET8.143sec
19.8.2024PRINS RICHARD K◇ GAVE-1.500sec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q230.7.20260,910,61+48.3%+48.3%Beat
2026Q130.4.20260,420,71-40.5%-40.5%Miss
2025Q430.1.20260,730,92-20.5%-20.5%Miss
2025Q330.10.20250,930,83+12.7%+12.7%Beat
2025Q230.7.20250,850,74+14.6%+14.6%Beat